CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,026,494 | -5.7% | 2,306,798 | -16.2% | 0.00% | 0.0% |
Q2 2023 | $11,693,832 | -16.3% | 2,751,490 | +4.5% | 0.00% | 0.0% |
Q1 2023 | $13,977,965 | +20.7% | 2,632,385 | +42.8% | 0.00% | 0.0% |
Q4 2022 | $11,579,704 | +525.6% | 1,843,902 | +950.6% | 0.00% | – |
Q3 2022 | $1,851,000 | +366.2% | 175,507 | +139.9% | 0.00% | – |
Q2 2022 | $397,000 | +120.6% | 73,146 | +273.7% | 0.00% | – |
Q1 2022 | $180,000 | -86.8% | 19,576 | -78.3% | 0.00% | – |
Q4 2021 | $1,360,000 | +65.7% | 90,142 | +162.2% | 0.00% | – |
Q3 2021 | $821,000 | – | 34,375 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |